MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Anxiety"

  • 2024 International Congress

    A Randomized, Double-Blind, Placebo-Controlled Trial of a Multi-Strain Probiotic for Anxiety in Parkinson’s Disease

    J. Lam, P. Uzelman, J. Zhu, D. Meng, F. Pio, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To evaluate the effect of a multi-strain probiotic on anxiety in patients with Parkinson’s disease (PD). Background: There is a lack of dedicated randomized…
  • 2024 International Congress

    Investigating an Emerging Anxiety-like Phenotype in a Novel Bilateral Rodent Model of Parkinsonian Alpha-Synuclein Pathology

    N. Lipari, I. Sandoval, F. Manfredsson, C. Bishop (Binghamton, USA)

    Objective: Investigate an emerging anxiety-like phenotype at various timepoints in a novel bilateral rodent model of parkinsonian alpha-synuclein pathology. Background: Parkinson’s Disease (PD) anxiety poses…
  • 2024 International Congress

    Effect of Target Selection on Mood, Pain, and Medications after DBS in PD

    J. Jiao, B. Brumbach, Y. Lin, A. Ko, D. Safarpour (Palo Alto, USA)

    Objective: To describe the association between medication adjustments with mood and pain following bilateral deep brain stimulation (DBS) in Parkinson’s disease (PD). Background: Depression, anxiety,…
  • 2024 International Congress

    Unwinding Anxiety: Feasibility and Effectiveness of App-Based Mindfulness Training for People with Anxiety and Parkinson’s Disease: A Pilot Study

    E. Weisbach, A. Demarco, J. Molino, A. Seritan, P. Prakash (Providence, USA)

    Objective: To assess whether an app-based mindfulness training (MT) intervention, “Unwinding Anxiety”, can be used for Parkinson’s Disease (PD) patients with mild-moderate anxiety to reduce…
  • 2024 International Congress

    Nocturnal Blood Pressure, Non-Dipping, Psychosis And Non-Motor Symptoms In Early Stages Of Huntington’s Disease Patients

    R. Singh, V. Sharma (New Delhi, India)

    Objective: The aim of this study was to determine the relationship between 24 h ambulatory blood pressure measurements (ABPM), i.e., absence or presence of nocturnal…
  • 2024 International Congress

    Prevalence and characteristics of anxiety in Parkinson’s disease

    I. Murasan, S. Diaconu, L. Ungureanu, I. Despa, A. Zarnoveanu, B. Opritoiu, C. Falup-Pecurariu (Brasov, Romania)

    Objective: To evaluate the characteristics of anxiety in relation to motor and non-motor symptoms in a cohort of PD patients. Background: Anxiety is a frequent…
  • 2024 International Congress

    Measuring Cortisol Levels in Persons with Huntington’s Disease

    A. Clarke, B. Lobb, A. Hiller (Portland, USA)

    Objective: To assess subjective and objective measures of emotional stress via standardized scales and a physiological measure (salivary cortisol) in persons with Huntington’s Disease (HD)…
  • 2024 International Congress

    Untangling Bidirectional Influences of Somatic and Internalizing Symptoms among People with Parkinson’s Disease: A Retrospective Cohort Study

    E. Demarco, D. Subramaniam, J. Scherrer, G. Grossberg, L. Hinyard (St. Louis, USA)

    Objective: Among patients with PD, determine if there is a bidirectional association between severity of somatic & internalizing symptoms over 3 years. Background: Among people…
  • 2024 International Congress

    Social phobia, anxiety and depression in patients with essential tremor

    S. Shtaimets, а. Shtraub, N. Zhukova, YU. Lalov, L. Tkachenko, I. Zhukova, A. Agasheva, D. Novotnyy (Omsk, Russian Federation)

    Objective: ET is the most diagnosed movement disorder, the frequency of which increases as a person ages. Background: To examine the incidence of social phobia,…
  • 2024 International Congress

    Clinical Predictors of Impulse Control Disorders in Parkinson’s Disease

    T. Breddy, P. Macdonald, K. van Hedger, H. Ganjavi (London, Canada)

    Objective: To investigate whether anxiety, depression, and sleep impairment relate to development of impulse control disorders (ICD) in patients with early-stage Parkinson’s disease (PD). Background:…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley